Medical Care
Global New Chemical Entities (NCE) CDMO Market Research Report 2025
- Mar 11, 25
- ID: 18740
- Pages: 84
- Figures: 86
- Views: 19
The global market for New Chemical Entities (NCE) CDMO was valued at US$ 2614 million in the year 2024 and is projected to reach a revised size of US$ 5607 million by 2031, growing at a CAGR of 11.4% during the forecast period.
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.
North American market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for New Chemical Entities (NCE) CDMO in Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for New Chemical Entities (NCE) CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Chemical Entities (NCE) CDMO.
The New Chemical Entities (NCE) CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Chemical Entities (NCE) CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Chemical Entities (NCE) CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KATSURA CHEMICAL CO., LTD
Regis Custom API
Neuland Laboratories Ltd.
Aspen API
Sai Life Sciences
Fermion
Dipharma Francis Srl (Dipharma)
Cohance
Suven Pharma
Syngene
Aarti Pharmalabs Limited (APL)
Cerbios-Pharma SA
PharmaBlock Sciences Nanjing Inc
Segment by Type
Peptide NCE
Oligonucleotide NCE
Other
Segment by Application
Tumors
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of New Chemical Entities (NCE) CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.
North American market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for New Chemical Entities (NCE) CDMO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for New Chemical Entities (NCE) CDMO in Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of New Chemical Entities (NCE) CDMO include KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, Fermion, Dipharma Francis Srl (Dipharma), Cohance, Suven Pharma, Syngene, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for New Chemical Entities (NCE) CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding New Chemical Entities (NCE) CDMO.
The New Chemical Entities (NCE) CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global New Chemical Entities (NCE) CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the New Chemical Entities (NCE) CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KATSURA CHEMICAL CO., LTD
Regis Custom API
Neuland Laboratories Ltd.
Aspen API
Sai Life Sciences
Fermion
Dipharma Francis Srl (Dipharma)
Cohance
Suven Pharma
Syngene
Aarti Pharmalabs Limited (APL)
Cerbios-Pharma SA
PharmaBlock Sciences Nanjing Inc
Segment by Type
Peptide NCE
Oligonucleotide NCE
Other
Segment by Application
Tumors
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of New Chemical Entities (NCE) CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Peptide NCE
1.2.3 Oligonucleotide NCE
1.2.4 Other
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) CDMO Market Perspective (2020-2031)
2.2 Global New Chemical Entities (NCE) CDMO Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Chemical Entities (NCE) CDMO Historic Market Size by Region (2020-2025)
2.2.3 New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031)
2.3 New Chemical Entities (NCE) CDMO Market Dynamics
2.3.1 New Chemical Entities (NCE) CDMO Industry Trends
2.3.2 New Chemical Entities (NCE) CDMO Market Drivers
2.3.3 New Chemical Entities (NCE) CDMO Market Challenges
2.3.4 New Chemical Entities (NCE) CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue (2020-2025)
3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Players (2020-2025)
3.2 Global New Chemical Entities (NCE) CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) CDMO Revenue
3.4 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) CDMO Revenue in 2024
3.5 Global Key Players of New Chemical Entities (NCE) CDMO Head office and Area Served
3.6 Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
3.7 Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) CDMO Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Type (2020-2025)
4.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031)
5 New Chemical Entities (NCE) CDMO Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Application (2020-2025)
5.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America New Chemical Entities (NCE) CDMO Market Size (2020-2031)
6.2 North America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
6.4 North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) CDMO Market Size (2020-2031)
7.2 Europe New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
7.4 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size (2020-2031)
8.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Chemical Entities (NCE) CDMO Market Size (2020-2031)
9.2 Latin America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
9.4 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size (2020-2031)
10.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 Regis Custom API
11.2.1 Regis Custom API Company Details
11.2.2 Regis Custom API Business Overview
11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Introduction
11.2.4 Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.2.5 Regis Custom API Recent Development
11.3 Neuland Laboratories Ltd.
11.3.1 Neuland Laboratories Ltd. Company Details
11.3.2 Neuland Laboratories Ltd. Business Overview
11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Introduction
11.3.4 Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.3.5 Neuland Laboratories Ltd. Recent Development
11.4 Aspen API
11.4.1 Aspen API Company Details
11.4.2 Aspen API Business Overview
11.4.3 Aspen API New Chemical Entities (NCE) CDMO Introduction
11.4.4 Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.4.5 Aspen API Recent Development
11.5 Sai Life Sciences
11.5.1 Sai Life Sciences Company Details
11.5.2 Sai Life Sciences Business Overview
11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Introduction
11.5.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.5.5 Sai Life Sciences Recent Development
11.6 Fermion
11.6.1 Fermion Company Details
11.6.2 Fermion Business Overview
11.6.3 Fermion New Chemical Entities (NCE) CDMO Introduction
11.6.4 Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.6.5 Fermion Recent Development
11.7 Dipharma Francis Srl (Dipharma)
11.7.1 Dipharma Francis Srl (Dipharma) Company Details
11.7.2 Dipharma Francis Srl (Dipharma) Business Overview
11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Introduction
11.7.4 Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.7.5 Dipharma Francis Srl (Dipharma) Recent Development
11.8 Cohance
11.8.1 Cohance Company Details
11.8.2 Cohance Business Overview
11.8.3 Cohance New Chemical Entities (NCE) CDMO Introduction
11.8.4 Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.8.5 Cohance Recent Development
11.9 Suven Pharma
11.9.1 Suven Pharma Company Details
11.9.2 Suven Pharma Business Overview
11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Introduction
11.9.4 Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.9.5 Suven Pharma Recent Development
11.10 Syngene
11.10.1 Syngene Company Details
11.10.2 Syngene Business Overview
11.10.3 Syngene New Chemical Entities (NCE) CDMO Introduction
11.10.4 Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.10.5 Syngene Recent Development
11.11 Aarti Pharmalabs Limited (APL)
11.11.1 Aarti Pharmalabs Limited (APL) Company Details
11.11.2 Aarti Pharmalabs Limited (APL) Business Overview
11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Introduction
11.11.4 Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.11.5 Aarti Pharmalabs Limited (APL) Recent Development
11.12 Cerbios-Pharma SA
11.12.1 Cerbios-Pharma SA Company Details
11.12.2 Cerbios-Pharma SA Business Overview
11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Introduction
11.12.4 Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.12.5 Cerbios-Pharma SA Recent Development
11.13 PharmaBlock Sciences Nanjing Inc
11.13.1 PharmaBlock Sciences Nanjing Inc Company Details
11.13.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Introduction
11.13.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.13.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Peptide NCE
1.2.3 Oligonucleotide NCE
1.2.4 Other
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) CDMO Market Perspective (2020-2031)
2.2 Global New Chemical Entities (NCE) CDMO Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 New Chemical Entities (NCE) CDMO Historic Market Size by Region (2020-2025)
2.2.3 New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031)
2.3 New Chemical Entities (NCE) CDMO Market Dynamics
2.3.1 New Chemical Entities (NCE) CDMO Industry Trends
2.3.2 New Chemical Entities (NCE) CDMO Market Drivers
2.3.3 New Chemical Entities (NCE) CDMO Market Challenges
2.3.4 New Chemical Entities (NCE) CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) CDMO Players by Revenue (2020-2025)
3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Players (2020-2025)
3.2 Global New Chemical Entities (NCE) CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) CDMO Revenue
3.4 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) CDMO Revenue in 2024
3.5 Global Key Players of New Chemical Entities (NCE) CDMO Head office and Area Served
3.6 Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
3.7 Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) CDMO Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Type (2020-2025)
4.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031)
5 New Chemical Entities (NCE) CDMO Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) CDMO Historic Market Size by Application (2020-2025)
5.2 Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America New Chemical Entities (NCE) CDMO Market Size (2020-2031)
6.2 North America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
6.4 North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) CDMO Market Size (2020-2031)
7.2 Europe New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
7.4 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size (2020-2031)
8.2 Asia-Pacific New Chemical Entities (NCE) CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America New Chemical Entities (NCE) CDMO Market Size (2020-2031)
9.2 Latin America New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
9.4 Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size (2020-2031)
10.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 Regis Custom API
11.2.1 Regis Custom API Company Details
11.2.2 Regis Custom API Business Overview
11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Introduction
11.2.4 Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.2.5 Regis Custom API Recent Development
11.3 Neuland Laboratories Ltd.
11.3.1 Neuland Laboratories Ltd. Company Details
11.3.2 Neuland Laboratories Ltd. Business Overview
11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Introduction
11.3.4 Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.3.5 Neuland Laboratories Ltd. Recent Development
11.4 Aspen API
11.4.1 Aspen API Company Details
11.4.2 Aspen API Business Overview
11.4.3 Aspen API New Chemical Entities (NCE) CDMO Introduction
11.4.4 Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.4.5 Aspen API Recent Development
11.5 Sai Life Sciences
11.5.1 Sai Life Sciences Company Details
11.5.2 Sai Life Sciences Business Overview
11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Introduction
11.5.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.5.5 Sai Life Sciences Recent Development
11.6 Fermion
11.6.1 Fermion Company Details
11.6.2 Fermion Business Overview
11.6.3 Fermion New Chemical Entities (NCE) CDMO Introduction
11.6.4 Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.6.5 Fermion Recent Development
11.7 Dipharma Francis Srl (Dipharma)
11.7.1 Dipharma Francis Srl (Dipharma) Company Details
11.7.2 Dipharma Francis Srl (Dipharma) Business Overview
11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Introduction
11.7.4 Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.7.5 Dipharma Francis Srl (Dipharma) Recent Development
11.8 Cohance
11.8.1 Cohance Company Details
11.8.2 Cohance Business Overview
11.8.3 Cohance New Chemical Entities (NCE) CDMO Introduction
11.8.4 Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.8.5 Cohance Recent Development
11.9 Suven Pharma
11.9.1 Suven Pharma Company Details
11.9.2 Suven Pharma Business Overview
11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Introduction
11.9.4 Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.9.5 Suven Pharma Recent Development
11.10 Syngene
11.10.1 Syngene Company Details
11.10.2 Syngene Business Overview
11.10.3 Syngene New Chemical Entities (NCE) CDMO Introduction
11.10.4 Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.10.5 Syngene Recent Development
11.11 Aarti Pharmalabs Limited (APL)
11.11.1 Aarti Pharmalabs Limited (APL) Company Details
11.11.2 Aarti Pharmalabs Limited (APL) Business Overview
11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Introduction
11.11.4 Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.11.5 Aarti Pharmalabs Limited (APL) Recent Development
11.12 Cerbios-Pharma SA
11.12.1 Cerbios-Pharma SA Company Details
11.12.2 Cerbios-Pharma SA Business Overview
11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Introduction
11.12.4 Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.12.5 Cerbios-Pharma SA Recent Development
11.13 PharmaBlock Sciences Nanjing Inc
11.13.1 PharmaBlock Sciences Nanjing Inc Company Details
11.13.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Introduction
11.13.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025)
11.13.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Peptide NCE
Table 3. Key Players of Oligonucleotide NCE
Table 4. Key Players of Other
Table 5. Global New Chemical Entities (NCE) CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global New Chemical Entities (NCE) CDMO Market Share by Region (2020-2025)
Table 9. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global New Chemical Entities (NCE) CDMO Market Share by Region (2026-2031)
Table 11. New Chemical Entities (NCE) CDMO Market Trends
Table 12. New Chemical Entities (NCE) CDMO Market Drivers
Table 13. New Chemical Entities (NCE) CDMO Market Challenges
Table 14. New Chemical Entities (NCE) CDMO Market Restraints
Table 15. Global New Chemical Entities (NCE) CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global New Chemical Entities (NCE) CDMO Market Share by Players (2020-2025)
Table 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
Table 18. Ranking of Global Top New Chemical Entities (NCE) CDMO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of New Chemical Entities (NCE) CDMO, Headquarters and Area Served
Table 21. Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
Table 22. Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2020-2025)
Table 26. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2026-2031)
Table 28. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2020-2025)
Table 30. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2026-2031)
Table 32. North America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 47. KATSURA CHEMICAL CO., LTD Company Details
Table 48. KATSURA CHEMICAL CO., LTD Business Overview
Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product
Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 51. KATSURA CHEMICAL CO., LTD Recent Development
Table 52. Regis Custom API Company Details
Table 53. Regis Custom API Business Overview
Table 54. Regis Custom API New Chemical Entities (NCE) CDMO Product
Table 55. Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 56. Regis Custom API Recent Development
Table 57. Neuland Laboratories Ltd. Company Details
Table 58. Neuland Laboratories Ltd. Business Overview
Table 59. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product
Table 60. Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 61. Neuland Laboratories Ltd. Recent Development
Table 62. Aspen API Company Details
Table 63. Aspen API Business Overview
Table 64. Aspen API New Chemical Entities (NCE) CDMO Product
Table 65. Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 66. Aspen API Recent Development
Table 67. Sai Life Sciences Company Details
Table 68. Sai Life Sciences Business Overview
Table 69. Sai Life Sciences New Chemical Entities (NCE) CDMO Product
Table 70. Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 71. Sai Life Sciences Recent Development
Table 72. Fermion Company Details
Table 73. Fermion Business Overview
Table 74. Fermion New Chemical Entities (NCE) CDMO Product
Table 75. Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 76. Fermion Recent Development
Table 77. Dipharma Francis Srl (Dipharma) Company Details
Table 78. Dipharma Francis Srl (Dipharma) Business Overview
Table 79. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product
Table 80. Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 81. Dipharma Francis Srl (Dipharma) Recent Development
Table 82. Cohance Company Details
Table 83. Cohance Business Overview
Table 84. Cohance New Chemical Entities (NCE) CDMO Product
Table 85. Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 86. Cohance Recent Development
Table 87. Suven Pharma Company Details
Table 88. Suven Pharma Business Overview
Table 89. Suven Pharma New Chemical Entities (NCE) CDMO Product
Table 90. Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 91. Suven Pharma Recent Development
Table 92. Syngene Company Details
Table 93. Syngene Business Overview
Table 94. Syngene New Chemical Entities (NCE) CDMO Product
Table 95. Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 96. Syngene Recent Development
Table 97. Aarti Pharmalabs Limited (APL) Company Details
Table 98. Aarti Pharmalabs Limited (APL) Business Overview
Table 99. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product
Table 100. Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 101. Aarti Pharmalabs Limited (APL) Recent Development
Table 102. Cerbios-Pharma SA Company Details
Table 103. Cerbios-Pharma SA Business Overview
Table 104. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product
Table 105. Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 106. Cerbios-Pharma SA Recent Development
Table 107. PharmaBlock Sciences Nanjing Inc Company Details
Table 108. PharmaBlock Sciences Nanjing Inc Business Overview
Table 109. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product
Table 110. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 111. PharmaBlock Sciences Nanjing Inc Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. New Chemical Entities (NCE) CDMO Picture
Figure 2. Global New Chemical Entities (NCE) CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global New Chemical Entities (NCE) CDMO Market Share by Type: 2024 VS 2031
Figure 4. Peptide NCE Features
Figure 5. Oligonucleotide NCE Features
Figure 6. Other Features
Figure 7. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global New Chemical Entities (NCE) CDMO Market Share by Application: 2024 VS 2031
Figure 9. Tumors Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. New Chemical Entities (NCE) CDMO Report Years Considered
Figure 13. Global New Chemical Entities (NCE) CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global New Chemical Entities (NCE) CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global New Chemical Entities (NCE) CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global New Chemical Entities (NCE) CDMO Market Share by Players in 2024
Figure 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) CDMO Revenue in 2024
Figure 19. North America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 21. United States New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 25. Germany New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Region (2020-2031)
Figure 33. China New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 41. Mexico New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 45. Turkey New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 49. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 50. Neuland Laboratories Ltd. Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 51. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 52. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 53. Fermion Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 54. Dipharma Francis Srl (Dipharma) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 55. Cohance Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 56. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 57. Syngene Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 58. Aarti Pharmalabs Limited (APL) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 59. Cerbios-Pharma SA Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 60. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Peptide NCE
Table 3. Key Players of Oligonucleotide NCE
Table 4. Key Players of Other
Table 5. Global New Chemical Entities (NCE) CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global New Chemical Entities (NCE) CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global New Chemical Entities (NCE) CDMO Market Share by Region (2020-2025)
Table 9. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global New Chemical Entities (NCE) CDMO Market Share by Region (2026-2031)
Table 11. New Chemical Entities (NCE) CDMO Market Trends
Table 12. New Chemical Entities (NCE) CDMO Market Drivers
Table 13. New Chemical Entities (NCE) CDMO Market Challenges
Table 14. New Chemical Entities (NCE) CDMO Market Restraints
Table 15. Global New Chemical Entities (NCE) CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global New Chemical Entities (NCE) CDMO Market Share by Players (2020-2025)
Table 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
Table 18. Ranking of Global Top New Chemical Entities (NCE) CDMO Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of New Chemical Entities (NCE) CDMO, Headquarters and Area Served
Table 21. Global Key Players of New Chemical Entities (NCE) CDMO, Product and Application
Table 22. Global Key Players of New Chemical Entities (NCE) CDMO, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global New Chemical Entities (NCE) CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2020-2025)
Table 26. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Type (2026-2031)
Table 28. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2020-2025)
Table 30. Global New Chemical Entities (NCE) CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Application (2026-2031)
Table 32. North America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 47. KATSURA CHEMICAL CO., LTD Company Details
Table 48. KATSURA CHEMICAL CO., LTD Business Overview
Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product
Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 51. KATSURA CHEMICAL CO., LTD Recent Development
Table 52. Regis Custom API Company Details
Table 53. Regis Custom API Business Overview
Table 54. Regis Custom API New Chemical Entities (NCE) CDMO Product
Table 55. Regis Custom API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 56. Regis Custom API Recent Development
Table 57. Neuland Laboratories Ltd. Company Details
Table 58. Neuland Laboratories Ltd. Business Overview
Table 59. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product
Table 60. Neuland Laboratories Ltd. Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 61. Neuland Laboratories Ltd. Recent Development
Table 62. Aspen API Company Details
Table 63. Aspen API Business Overview
Table 64. Aspen API New Chemical Entities (NCE) CDMO Product
Table 65. Aspen API Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 66. Aspen API Recent Development
Table 67. Sai Life Sciences Company Details
Table 68. Sai Life Sciences Business Overview
Table 69. Sai Life Sciences New Chemical Entities (NCE) CDMO Product
Table 70. Sai Life Sciences Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 71. Sai Life Sciences Recent Development
Table 72. Fermion Company Details
Table 73. Fermion Business Overview
Table 74. Fermion New Chemical Entities (NCE) CDMO Product
Table 75. Fermion Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 76. Fermion Recent Development
Table 77. Dipharma Francis Srl (Dipharma) Company Details
Table 78. Dipharma Francis Srl (Dipharma) Business Overview
Table 79. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product
Table 80. Dipharma Francis Srl (Dipharma) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 81. Dipharma Francis Srl (Dipharma) Recent Development
Table 82. Cohance Company Details
Table 83. Cohance Business Overview
Table 84. Cohance New Chemical Entities (NCE) CDMO Product
Table 85. Cohance Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 86. Cohance Recent Development
Table 87. Suven Pharma Company Details
Table 88. Suven Pharma Business Overview
Table 89. Suven Pharma New Chemical Entities (NCE) CDMO Product
Table 90. Suven Pharma Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 91. Suven Pharma Recent Development
Table 92. Syngene Company Details
Table 93. Syngene Business Overview
Table 94. Syngene New Chemical Entities (NCE) CDMO Product
Table 95. Syngene Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 96. Syngene Recent Development
Table 97. Aarti Pharmalabs Limited (APL) Company Details
Table 98. Aarti Pharmalabs Limited (APL) Business Overview
Table 99. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product
Table 100. Aarti Pharmalabs Limited (APL) Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 101. Aarti Pharmalabs Limited (APL) Recent Development
Table 102. Cerbios-Pharma SA Company Details
Table 103. Cerbios-Pharma SA Business Overview
Table 104. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product
Table 105. Cerbios-Pharma SA Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 106. Cerbios-Pharma SA Recent Development
Table 107. PharmaBlock Sciences Nanjing Inc Company Details
Table 108. PharmaBlock Sciences Nanjing Inc Business Overview
Table 109. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product
Table 110. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) CDMO Business (2020-2025) & (US$ Million)
Table 111. PharmaBlock Sciences Nanjing Inc Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. New Chemical Entities (NCE) CDMO Picture
Figure 2. Global New Chemical Entities (NCE) CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global New Chemical Entities (NCE) CDMO Market Share by Type: 2024 VS 2031
Figure 4. Peptide NCE Features
Figure 5. Oligonucleotide NCE Features
Figure 6. Other Features
Figure 7. Global New Chemical Entities (NCE) CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global New Chemical Entities (NCE) CDMO Market Share by Application: 2024 VS 2031
Figure 9. Tumors Case Studies
Figure 10. Cardiovascular Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. New Chemical Entities (NCE) CDMO Report Years Considered
Figure 13. Global New Chemical Entities (NCE) CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global New Chemical Entities (NCE) CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global New Chemical Entities (NCE) CDMO Market Share by Region: 2024 VS 2031
Figure 16. Global New Chemical Entities (NCE) CDMO Market Share by Players in 2024
Figure 17. Global Top New Chemical Entities (NCE) CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in New Chemical Entities (NCE) CDMO as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) CDMO Revenue in 2024
Figure 19. North America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 21. United States New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 25. Germany New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific New Chemical Entities (NCE) CDMO Market Share by Region (2020-2031)
Figure 33. China New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 41. Mexico New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa New Chemical Entities (NCE) CDMO Market Share by Country (2020-2031)
Figure 45. Turkey New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE New Chemical Entities (NCE) CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 49. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 50. Neuland Laboratories Ltd. Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 51. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 52. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 53. Fermion Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 54. Dipharma Francis Srl (Dipharma) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 55. Cohance Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 56. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 57. Syngene Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 58. Aarti Pharmalabs Limited (APL) Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 59. Cerbios-Pharma SA Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 60. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) CDMO Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232